The Greater Cannabis Company, Inc.
GCAN
The Greater Cannabis Company, Inc. engages in the development and... The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company has a license agreement with Shaare Zedek Scientific Ltd. that focuses on treatment of autism, schizophrenia, Parkinsonโs disease, Alzheimerโs disease, and other neuropsychiatric disorders. The company was founded in 2014 and is based in Baltimore, Maryland.